Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - PRE-TAX INCOME
Pre-tax Income KALV - KalVista Pharmaceuticals, Inc.
-135 M
LAST VALUE
-28.09%
2 YEAR CAGR
-45.54%
5 YEAR CAGR
-37.29%
10 YEAR CAGR